 | • レポートコード：MRC2312MG06957 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、61ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の禁煙用ニコチン代替療法市場規模と予測を収録しています。・世界の禁煙用ニコチン代替療法市場：売上、2018年-2023年、2024年-2029年 ・世界の禁煙用ニコチン代替療法市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の禁煙用ニコチン代替療法市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「スプレー＆吸入器」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 禁煙用ニコチン代替療法のグローバル主要企業は、Pfizer、 Cipla、 Novartis、 GlaxoSmithKline、 Johnson & Johnson、 Philip Morris、 Perrigo Company、 Alkalon、 Ventus Medicalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、禁煙用ニコチン代替療法のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の禁煙用ニコチン代替療法市場：タイプ別、2018年-2023年、2024年-2029年 世界の禁煙用ニコチン代替療法市場：タイプ別市場シェア、2022年 ・スプレー＆吸入器、ガム、パッチ、トローチ 世界の禁煙用ニコチン代替療法市場：用途別、2018年-2023年、2024年-2029年 世界の禁煙用ニコチン代替療法市場：用途別市場シェア、2022年 ・薬局、スーパー、病院、その他 世界の禁煙用ニコチン代替療法市場：地域・国別、2018年-2023年、2024年-2029年 世界の禁煙用ニコチン代替療法市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における禁煙用ニコチン代替療法のグローバル売上、2018年-2023年 ・主要企業における禁煙用ニコチン代替療法のグローバル売上シェア、2022年 ・主要企業における禁煙用ニコチン代替療法のグローバル販売量、2018年-2023年 ・主要企業における禁煙用ニコチン代替療法のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Pfizer、 Cipla、 Novartis、 GlaxoSmithKline、 Johnson & Johnson、 Philip Morris、 Perrigo Company、 Alkalon、 Ventus Medical ************************************************************* ・調査・分析レポートの概要 禁煙用ニコチン代替療法市場の定義 市場セグメント 世界の禁煙用ニコチン代替療法市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の禁煙用ニコチン代替療法市場規模 世界の禁煙用ニコチン代替療法市場規模：2022年 VS 2029年 世界の禁煙用ニコチン代替療法市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの禁煙用ニコチン代替療法の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の禁煙用ニコチン代替療法製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：スプレー＆吸入器、ガム、パッチ、トローチ 禁煙用ニコチン代替療法のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：薬局、スーパー、病院、その他 禁煙用ニコチン代替療法の用途別グローバル売上・予測 ・地域別市場分析 地域別禁煙用ニコチン代替療法市場規模 2022年と2029年 地域別禁煙用ニコチン代替療法売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Pfizer、 Cipla、 Novartis、 GlaxoSmithKline、 Johnson & Johnson、 Philip Morris、 Perrigo Company、 Alkalon、 Ventus Medical ... |
This research report provides a comprehensive analysis of the Nicotine Replacement Therapy for Smoking Cessation market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Nicotine Replacement Therapy for Smoking Cessation market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Nicotine Replacement Therapy for Smoking Cessation, challenges faced by the industry, and potential opportunities for market players.
The global Nicotine Replacement Therapy for Smoking Cessation market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Nicotine Replacement Therapy for Smoking Cessation market presents opportunities for various stakeholders, including Pharmacy, Supermarket. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Nicotine Replacement Therapy for Smoking Cessation market. Additionally, the growing consumer demand present avenues for market expansion.
The global Nicotine Replacement Therapy for Smoking Cessation market was valued at US$ 494.2 million in 2022 and is projected to reach US$ 696 million by 2029, at a CAGR of 5.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Nicotine Replacement Therapy for Smoking Cessation market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Nicotine Replacement Therapy for Smoking Cessation market.
Market Overview: The report provides a comprehensive overview of the Nicotine Replacement Therapy for Smoking Cessation market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Sprays and Inhalers, Gums), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Nicotine Replacement Therapy for Smoking Cessation market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Nicotine Replacement Therapy for Smoking Cessation market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Nicotine Replacement Therapy for Smoking Cessation market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Nicotine Replacement Therapy for Smoking Cessation market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Nicotine Replacement Therapy for Smoking Cessation market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Nicotine Replacement Therapy for Smoking Cessation market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Nicotine Replacement Therapy for Smoking Cessation, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Nicotine Replacement Therapy for Smoking Cessation market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Nicotine Replacement Therapy for Smoking Cessation market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Sprays and Inhalers
Gums
Patches
Lozenges
Market segment by Application
Pharmacy
Supermarket
Hospital
Other
Global Nicotine Replacement Therapy for Smoking Cessation Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Pfizer
Cipla
Novartis
GlaxoSmithKline
Johnson & Johnson
Philip Morris
Perrigo Company
Alkalon
Ventus Medical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nicotine Replacement Therapy for Smoking Cessation, market overview.
Chapter 2: Global Nicotine Replacement Therapy for Smoking Cessation market size in revenue.
Chapter 3: Detailed analysis of Nicotine Replacement Therapy for Smoking Cessation company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nicotine Replacement Therapy for Smoking Cessation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Nicotine Replacement Therapy for Smoking Cessation Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nicotine Replacement Therapy for Smoking Cessation Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nicotine Replacement Therapy for Smoking Cessation Overall Market Size
2.1 Global Nicotine Replacement Therapy for Smoking Cessation Market Size: 2022 VS 2029
2.2 Global Nicotine Replacement Therapy for Smoking Cessation Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nicotine Replacement Therapy for Smoking Cessation Players in Global Market
3.2 Top Global Nicotine Replacement Therapy for Smoking Cessation Companies Ranked by Revenue
3.3 Global Nicotine Replacement Therapy for Smoking Cessation Revenue by Companies
3.4 Top 3 and Top 5 Nicotine Replacement Therapy for Smoking Cessation Companies in Global Market, by Revenue in 2022
3.5 Global Companies Nicotine Replacement Therapy for Smoking Cessation Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nicotine Replacement Therapy for Smoking Cessation Players in Global Market
3.6.1 List of Global Tier 1 Nicotine Replacement Therapy for Smoking Cessation Companies
3.6.2 List of Global Tier 2 and Tier 3 Nicotine Replacement Therapy for Smoking Cessation Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Nicotine Replacement Therapy for Smoking Cessation Market Size Markets, 2022 & 2029
4.1.2 Sprays and Inhalers
4.1.3 Gums
4.1.4 Patches
4.1.5 Lozenges
4.2 By Type – Global Nicotine Replacement Therapy for Smoking Cessation Revenue & Forecasts
4.2.1 By Type – Global Nicotine Replacement Therapy for Smoking Cessation Revenue, 2018-2023
4.2.2 By Type – Global Nicotine Replacement Therapy for Smoking Cessation Revenue, 2024-2029
4.2.3 By Type – Global Nicotine Replacement Therapy for Smoking Cessation Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Nicotine Replacement Therapy for Smoking Cessation Market Size, 2022 & 2029
5.1.2 Pharmacy
5.1.3 Supermarket
5.1.4 Hospital
5.1.5 Other
5.2 By Application – Global Nicotine Replacement Therapy for Smoking Cessation Revenue & Forecasts
5.2.1 By Application – Global Nicotine Replacement Therapy for Smoking Cessation Revenue, 2018-2023
5.2.2 By Application – Global Nicotine Replacement Therapy for Smoking Cessation Revenue, 2024-2029
5.2.3 By Application – Global Nicotine Replacement Therapy for Smoking Cessation Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Nicotine Replacement Therapy for Smoking Cessation Market Size, 2022 & 2029
6.2 By Region – Global Nicotine Replacement Therapy for Smoking Cessation Revenue & Forecasts
6.2.1 By Region – Global Nicotine Replacement Therapy for Smoking Cessation Revenue, 2018-2023
6.2.2 By Region – Global Nicotine Replacement Therapy for Smoking Cessation Revenue, 2024-2029
6.2.3 By Region – Global Nicotine Replacement Therapy for Smoking Cessation Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Nicotine Replacement Therapy for Smoking Cessation Revenue, 2018-2029
6.3.2 US Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.3.3 Canada Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.3.4 Mexico Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Nicotine Replacement Therapy for Smoking Cessation Revenue, 2018-2029
6.4.2 Germany Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.4.3 France Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.4.4 U.K. Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.4.5 Italy Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.4.6 Russia Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.4.7 Nordic Countries Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.4.8 Benelux Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Nicotine Replacement Therapy for Smoking Cessation Revenue, 2018-2029
6.5.2 China Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.5.3 Japan Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.5.4 South Korea Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.5.5 Southeast Asia Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.5.6 India Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Nicotine Replacement Therapy for Smoking Cessation Revenue, 2018-2029
6.6.2 Brazil Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.6.3 Argentina Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Nicotine Replacement Therapy for Smoking Cessation Revenue, 2018-2029
6.7.2 Turkey Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.7.3 Israel Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.7.4 Saudi Arabia Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
6.7.5 UAE Nicotine Replacement Therapy for Smoking Cessation Market Size, 2018-2029
7 Nicotine Replacement Therapy for Smoking Cessation Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Nicotine Replacement Therapy for Smoking Cessation Major Product Offerings
7.1.4 Pfizer Nicotine Replacement Therapy for Smoking Cessation Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Cipla
7.2.1 Cipla Company Summary
7.2.2 Cipla Business Overview
7.2.3 Cipla Nicotine Replacement Therapy for Smoking Cessation Major Product Offerings
7.2.4 Cipla Nicotine Replacement Therapy for Smoking Cessation Revenue in Global Market (2018-2023)
7.2.5 Cipla Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Nicotine Replacement Therapy for Smoking Cessation Major Product Offerings
7.3.4 Novartis Nicotine Replacement Therapy for Smoking Cessation Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Nicotine Replacement Therapy for Smoking Cessation Major Product Offerings
7.4.4 GlaxoSmithKline Nicotine Replacement Therapy for Smoking Cessation Revenue in Global Market (2018-2023)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Nicotine Replacement Therapy for Smoking Cessation Major Product Offerings
7.5.4 Johnson & Johnson Nicotine Replacement Therapy for Smoking Cessation Revenue in Global Market (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Philip Morris
7.6.1 Philip Morris Company Summary
7.6.2 Philip Morris Business Overview
7.6.3 Philip Morris Nicotine Replacement Therapy for Smoking Cessation Major Product Offerings
7.6.4 Philip Morris Nicotine Replacement Therapy for Smoking Cessation Revenue in Global Market (2018-2023)
7.6.5 Philip Morris Key News & Latest Developments
7.7 Perrigo Company
7.7.1 Perrigo Company Company Summary
7.7.2 Perrigo Company Business Overview
7.7.3 Perrigo Company Nicotine Replacement Therapy for Smoking Cessation Major Product Offerings
7.7.4 Perrigo Company Nicotine Replacement Therapy for Smoking Cessation Revenue in Global Market (2018-2023)
7.7.5 Perrigo Company Key News & Latest Developments
7.8 Alkalon
7.8.1 Alkalon Company Summary
7.8.2 Alkalon Business Overview
7.8.3 Alkalon Nicotine Replacement Therapy for Smoking Cessation Major Product Offerings
7.8.4 Alkalon Nicotine Replacement Therapy for Smoking Cessation Revenue in Global Market (2018-2023)
7.8.5 Alkalon Key News & Latest Developments
7.9 Ventus Medical
7.9.1 Ventus Medical Company Summary
7.9.2 Ventus Medical Business Overview
7.9.3 Ventus Medical Nicotine Replacement Therapy for Smoking Cessation Major Product Offerings
7.9.4 Ventus Medical Nicotine Replacement Therapy for Smoking Cessation Revenue in Global Market (2018-2023)
7.9.5 Ventus Medical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
